Related Experiment Video
Updated: Aug 14, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
[Some clinical and immunological aspects of female pulmonary tuberculosis]
Expression of activation markers, such as CD25, HLA-DR), Fas-AG, CD16), on the lymphocytes was studied in female patients with tuberculosis (n = 40) and healthy donors. The level of antituberculous antibodies was measured in parallel in the sera of these patients. The above parameters were examined in relation to the nature of the microflora detected in these patients. Nonspecific co-infection in patients with active tuberculosis is an additional factor of activation of the immune system and simultaneously a factor that enhances the involvement of cells in apoptosis.
Expression of activation markers, such as CD25, HLA-DR), Fas-AG, CD16), on the lymphocytes was studied in female patients with tuberculosis (n = 40) and healthy donors. The level of antituberculous antibodies was measured in parallel in the sera of these patients. The above parameters were examined in relation to the nature of the microflora detected in these patients. Nonspecific co-infection in patients with active tuberculosis is an additional factor of activation of the immune system and simultaneously a factor that enhances the involvement of cells in apoptosis.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis